VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. (VRCA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 18, 2026 , by Kirby John J. .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Kirby John J. | Interim CFO | Buy | 5,000 | $4.93 | $24.7K | 23,962 | |
| Rosenberg Noah L. | CMO | Buy | 2,030 | $4.92 | $10.0K | 8,587 | |
| Zawitz David | Chief Operating Officer | Buy | 6,000 | $4.98 | $29.9K | 27,000 | |
| Rieger Jayson | CEO and President | Buy | 5,000 | $4.91 | $24.6K | 207,593 | |
| Rosenberg Noah L. | CMO | Buy | 4,200 | $4.91 | $20.6K | 6,557 | |
| Rieger Jayson | CEO and President | Buy | 20,000 | $5.06 | $101.2K | 202,593 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.